» Articles » PMID: 24493828

High-resolution Array CGH and Gene Expression Profiling of Alveolar Soft Part Sarcoma

Overview
Journal Clin Cancer Res
Specialty Oncology
Date 2014 Feb 5
PMID 24493828
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Alveolar soft part sarcoma (ASPS) is a soft tissue sarcoma with poor prognosis, and little molecular evidence exists for its origin, initiation, and progression. The aim of this study was to elucidate candidate molecular pathways involved in tumor pathogenesis.

Experimental Design: We employed high-throughput array comparative genomic hybridization (aCGH) and cDNA-Mediated Annealing, Selection, Ligation, and Extension Assay to profile the genomic and expression signatures of primary and metastatic ASPS from 17 tumors derived from 11 patients. We used an integrative bioinformatics approach to elucidate the molecular pathways associated with ASPS progression. FISH was performed to validate the presence of the t(X;17)(p11.2;q25) ASPL-TFE3 fusion and, hence, confirm the aCGH observations.

Results: FISH analysis identified the ASPL-TFE3 fusion in all cases. aCGH revealed a higher number of numerical aberrations in metastatic tumors relative to primaries, but failed to identify consistent alterations in either group. Gene expression analysis highlighted 1,063 genes that were differentially expressed between the two groups. Gene set enrichment analysis identified 16 enriched gene sets (P < 0.1) associated with differentially expressed genes. Notable among these were several stem cell gene expression signatures and pathways related to differentiation. In particular, the paired box transcription factor PAX6 was upregulated in the primary tumors, along with several genes whose mouse orthologs have previously been implicated in Pax6 DNA binding during neural stem cell differentiation.

Conclusion: In addition to suggesting a tentative neural line of differentiation for ASPS, these results implicate transcriptional deregulation from fusion genes in the pathogenesis of ASPS.

Citing Articles

ASPSCR1::TFE3 Drives Alveolar Soft Part Sarcoma by Inducing Targetable Transcriptional Programs.

Sicinska E, Kola V, Kerfoot J, Taddei M, Al-Ibraheemi A, Hsieh Y Cancer Res. 2024; 84(14):2247-2264.

PMID: 38657118 PMC: 11250573. DOI: 10.1158/0008-5472.CAN-23-2115.


Everolimus in combination with vandetanib in children, adolescents, and young adults: a phase I study.

Phadnis S, Wang X, Daw N, Herzog C, Subbiah I, Zaky W ESMO Open. 2023; 8(6):101609.

PMID: 37879233 PMC: 10774869. DOI: 10.1016/j.esmoop.2023.101609.


ASPSCR1::TFE3 orchestrates the angiogenic program of alveolar soft part sarcoma.

Tanaka M, Chuaychob S, Homme M, Yamazaki Y, Lyu R, Yamashita K Nat Commun. 2023; 14(1):1957.

PMID: 37029109 PMC: 10082046. DOI: 10.1038/s41467-023-37049-z.


Calreticulin Expression Controls Cellular Redox, Stemness, and Radiosensitivity to Function as a Novel Adjuvant for Radiotherapy in Neuroblastoma.

Chen C, Hu Y, Chien Y, Huang W, Wu C, Tsai C Oxid Med Cell Longev. 2023; 2023:8753309.

PMID: 36644580 PMC: 9839411. DOI: 10.1155/2023/8753309.


Alveolar soft-part sarcoma (ASPS) resembles a mesenchymal stromal progenitor: evidence from meta-analysis of transcriptomic data.

Stockwin L PeerJ. 2020; 8:e9394.

PMID: 32596059 PMC: 7307565. DOI: 10.7717/peerj.9394.


References
1.
Guillou L, Lamoureux E, Masse S, Costa J . Alveolar soft-part sarcoma of the uterine corpus: histological, immunocytochemical and ultrastructural study of a case. Virchows Arch A Pathol Anat Histopathol. 1991; 418(5):467-71. DOI: 10.1007/BF01605935. View

2.
Gasche J, Hoffmann J, Boland C, Goel A . Interleukin-6 promotes tumorigenesis by altering DNA methylation in oral cancer cells. Int J Cancer. 2011; 129(5):1053-63. PMC: 3110561. DOI: 10.1002/ijc.25764. View

3.
Foschini M, Eusebi V . Alveolar soft-part sarcoma: a new type of rhabdomyosarcoma?. Semin Diagn Pathol. 1994; 11(1):58-68. View

4.
Pesek M, Kopeckova M, Benesova L, Meszarosova A, Mukensnabl P, Bruha F . Clinical significance of hypermethylation status in NSCLC: evaluation of a 30-gene panel in patients with advanced disease. Anticancer Res. 2011; 31(12):4647-52. View

5.
Gomez J, Amin M, Ro J, Linden M, Lee M, Zarbo R . Immunohistochemical profile of myogenin and MyoD1 does not support skeletal muscle lineage in alveolar soft part sarcoma. Arch Pathol Lab Med. 1999; 123(6):503-7. DOI: 10.5858/1999-123-0503-IPOMAM. View